A Positively Charged α-Lipoic Acid Analogue with Increased Cellular Uptake and More Potent Immunomodulatory Activity

α-Lipoic acid (LA) is taken up by cells and reduced to its potent dithiol form, dihydrolipoate(DHLA), much of which is rapidly effluxed out from cells. To improve retention in cells, the LA molecule was modified to confer a positive charge at physiological pH. N,N-dimethyl,N′-2-amidoethyl-lipoate wa...

Full description

Saved in:
Bibliographic Details
Published in:Biochemical and biophysical research communications 1998-06, Vol.247 (2), p.223-228
Main Authors: Sen, Chandan K., Tirosh, Oren, Roy, Sashwati, Kobayashi, Michael S., Packer, Lester
Format: Article
Language:English
Subjects:
Adjuvants, Immunologic - chemistry
Adjuvants, Immunologic - pharmacokinetics
Adjuvants, Immunologic - pharmacology
Animals
Apoptosis - drug effects
Biological Transport, Active
Cell Line
DNA Fragmentation - drug effects
Electrochemistry
Etoposide - pharmacology
Humans
Hydrogen Peroxide - pharmacology
In Vitro Techniques
Male
NF-kappa B - metabolism
Rats
Rats, Sprague-Dawley
Receptors, Interleukin-2 - metabolism
T-Lymphocytes - cytology
T-Lymphocytes - drug effects
T-Lymphocytes - metabolism
Thioctic Acid - analogs & derivatives
Thioctic Acid - chemistry
Thioctic Acid - pharmacokinetics
Thioctic Acid - pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:α-Lipoic acid (LA) is taken up by cells and reduced to its potent dithiol form, dihydrolipoate(DHLA), much of which is rapidly effluxed out from cells. To improve retention in cells, the LA molecule was modified to confer a positive charge at physiological pH. N,N-dimethyl,N′-2-amidoethyl-lipoate was synthesized. The protonated form of the new molecule is referred to as LA-Plus. The uptake of LA-Plus by human Wurzburg T cells was higher compared to that of LA. Several-fold higher amounts of DHLA-Plus, the corresponding reduced form of LA-Plus, were detected in LA-Plus treated cells compared to the amount of DHLA found in cells treated with LA. At 100 μM, LA did not but LA-Plus inhibited H2O2induced NF-κB activation and NF-κB directed IL-2 receptor expression. Both LA and LA-Plus synergised with selenium in inhibiting H2O2induced NF-κB activation. At 150 μM LA-Plus, but not LA, inhibited TNFα induced NF-κB activation. At 5 μM LA-Plus, but not LA, protected against both spontaneous and etoposide induced apoptosis in rat thymocytes. LA-Plus is thus an improved form of LA with increased therapeutic potential.
ISSN:0006-291X
1090-2104
DOI:10.1006/bbrc.1998.8764